Tetraplegia

Encompass Health Rehabilitation Hospital of Fitchburg, a 56-bed inpatient rehabilitation hospital, now open in Wisconsin

Retrieved on: 
Wednesday, November 15, 2023

BIRMINGHAM, Ala. and FITCHBURG, Wis., Nov. 15, 2023 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Hospital of Fitchburg , a 56-bed inpatient rehabilitation hospital located at 5535 Nobel Drive.

Key Points: 
  • BIRMINGHAM, Ala. and FITCHBURG, Wis., Nov. 15, 2023 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Hospital of Fitchburg , a 56-bed inpatient rehabilitation hospital located at 5535 Nobel Drive.
  • The hospital serves patients recovering from debilitating illnesses and injuries including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.
  • "We are excited to open this rehabilitation hospital to help individuals recovering from major illnesses and injuries regain the strength and function needed to reach their highest levels of independence," said Dodi Purtell, CEO of Encompass Health Rehabilitation Hospital of Fitchburg.
  • Encompass Health Rehabilitation Hospital of Fitchburg is Encompass Health's 161st inpatient rehabilitation hospital nationwide and its second inpatient rehabilitation hospital in Wisconsin.

Encompass Health Rehabilitation Hospital of Prosper, a 40-bed inpatient rehabilitation hospital, now open in Texas

Retrieved on: 
Tuesday, November 14, 2023

BIRMINGHAM, Ala. and PROSPER, Texas, Nov. 14, 2023 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Hospital of Prosper , a 40-bed inpatient rehabilitation hospital located at 1231 Mahard Parkway.

Key Points: 
  • BIRMINGHAM, Ala. and PROSPER, Texas, Nov. 14, 2023 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Hospital of Prosper , a 40-bed inpatient rehabilitation hospital located at 1231 Mahard Parkway.
  • The hospital serves patients recovering from debilitating injuries and illnesses including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.
  • In addition to 24-hour registered nursing care, the hospital offers physical, occupational and speech therapies to restore functional ability and quality of life.
  • Encompass Health Rehabilitation Hospital of Prosper is Encompass Health's 160th inpatient rehabilitation hospital nationwide and its 27th hospital in Texas.

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

Retrieved on: 
Thursday, November 2, 2023

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its appreciation to the Centers for Medicare & Medicaid Services (“CMS”) for finalizing the Calendar Year 2024 Home Health Prospective Payment System Rule CMS-1780 (“2024 Home Health Rule”) which solidifies the inclusion of exoskeletons in the Medicare brace benefit category. The final rule was released by CMS on November 1, 2023 and will go into effect beginning on January 1, 2024.

Key Points: 
  • 2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons.
  • Final rule expedites access for Medicare beneficiaries to exoskeleton technology that enables individuals with spinal cord injury to stand, walk, and navigate stairs and curbs in everyday life.
  • The 2024 Home Health Rule finalizes a clear coverage pathway for exoskeletons within the Brace benefit category, which is reimbursed by Medicare on a lump-sum basis.
  • For more information about how to pursue a ReWalk Personal Exoskeleton, please visit rewalk.com/medicare .

WiMi Developed a Motor Imagery Brain-computer Interface Based on Multi-source Signal Processing

Retrieved on: 
Monday, November 6, 2023

BEIJING, Nov. 6, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a motor imagery brain-computer interface (MI-BCI) based on multi-source signal processing has been developed.

Key Points: 
  • BEIJING, Nov. 6, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a motor imagery brain-computer interface (MI-BCI) based on multi-source signal processing has been developed.
  • By introducing a multi-source signal processing approach, this innovative technology enables more accurate brain signal parsing and processing, providing users with higher control accuracy and wider application potential.
  • Its main features and key technology points:
    Multi-source signal processing: The technology employs an advanced multi-source signal processing method that utilizes multiple sources of EEG signals, not just channel signals.
  • Common spatial patterns (CSP): In the early stages of signal processing, CSP algorithms are applied to each sub-band to optimize the extraction of signal features.

Spinal Cord Injury Market Likely to Exhibit Substantial Growth by 2032, Assesses DelveInsight | Companies to Watch Out - NervGen Pharma, StemCyte, Mitsubishi Tanabe Pharma America, AbbVie

Retrieved on: 
Wednesday, November 1, 2023

LAS VEGAS, Nov. 1, 2023 /PRNewswire/ -- DelveInsight's Spinal Cord Injury Market Insights report includes a comprehensive understanding of current treatment practices, spinal cord injury emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Points: 
  • Leading spinal cord injury companies such as NervGen Pharma, VA Office of Research and Development, Kessler Institute for Rehabilitation, StemCyte, Inc., Mitsubishi Tanabe Pharma America Inc., AbbVie, and others are developing novel spinal cord injury drugs that can be available in the spinal cord injury market in the coming years.
  • Spinal cord injury represents a significant medical condition that results in a wide range of functional, psychological, and socioeconomic challenges.
  • The spinal cord injury epidemiology section provides insights into the historical and current spinal cord injury patient pool and forecasted trends for individual seven major countries.
  • To know more about spinal cord injury treatment, visit @ Spinal Cord Injury Treatment Drugs
    Umbilical Cord Blood Mononuclear Cell: StemCyte, Inc.
    MT-3921: Mitsubishi Tanabe Pharma America Inc.

Spinal Cord Injury Market Likely to Exhibit Substantial Growth by 2032, Assesses DelveInsight | Companies to Watch Out - NervGen Pharma, StemCyte, Mitsubishi Tanabe Pharma America, AbbVie

Retrieved on: 
Wednesday, November 1, 2023

LAS VEGAS, Nov. 1, 2023 /PRNewswire/ -- DelveInsight's Spinal Cord Injury Market Insights report includes a comprehensive understanding of current treatment practices, spinal cord injury emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Points: 
  • Leading spinal cord injury companies such as NervGen Pharma, VA Office of Research and Development, Kessler Institute for Rehabilitation, StemCyte, Inc., Mitsubishi Tanabe Pharma America Inc., AbbVie, and others are developing novel spinal cord injury drugs that can be available in the spinal cord injury market in the coming years.
  • Spinal cord injury represents a significant medical condition that results in a wide range of functional, psychological, and socioeconomic challenges.
  • The spinal cord injury epidemiology section provides insights into the historical and current spinal cord injury patient pool and forecasted trends for individual seven major countries.
  • To know more about spinal cord injury treatment, visit @ Spinal Cord Injury Treatment Drugs
    Umbilical Cord Blood Mononuclear Cell: StemCyte, Inc.
    MT-3921: Mitsubishi Tanabe Pharma America Inc.

Wandercraft announces launch of US commercial operations with the start of Atalante X research at Kessler Foundation

Retrieved on: 
Thursday, October 12, 2023

NEW YORK CITY, New York, 12 October 2023 -- Wandercraft, the developer of the world's first self-stabilizing walking exoskeleton, designed to enable people with walking impairments to stand and walk again, announced today the official launch of commercial operations in the United States with the start of Atalante X research at Kessler Foundation, a global leader in rehabilitation research.

Key Points: 
  • A large number of individuals with disabilities in the US may benefit from using the Atalante X exoskeleton.
  • In addition, approximately 302,000 people living in the United States have experienced a traumatic spinal cord injury according to the US National Spinal Cord Injury Statistical Center.
  • Finally, approximately one million people in the US are living with multiple sclerosis according to the National Multiple Sclerosis Society.
  • The CE marking represents a manufacturer's declaration that products comply with the EU's New Approach Directives.

CELEBRATING 30 YEARS: CHALLENGED ATHLETES FOUNDATION HOSTS ULTIMATE INCLUSIVE SPORTS EXPERIENCE FOR ATHLETES WITH PHYSICAL DISABILITIES

Retrieved on: 
Wednesday, October 11, 2023

These events mark three decades of transforming lives and creating inclusive opportunities for athletes with physical disabilities.

Key Points: 
  • These events mark three decades of transforming lives and creating inclusive opportunities for athletes with physical disabilities.
  • Participants will engage in a dynamic series of events that unite athletes, supporters, spectators, and volunteers in the mission of empowering individuals with physical disabilities through sports.
  • The annual event showcases the inspirational athletic spirit of over 200 athletes with physical challenges competing side-by-side with 600 plus athletes without physical disabilities.
  • Toyota's dedication to mobility and innovation aligns perfectly with CAF's vision of empowering athletes with physical disabilities.

Shriners Children's Partners with ThreePeaks Brands to Improve the Lives of Children

Retrieved on: 
Thursday, October 12, 2023

TAMPA, Fla., Oct. 12, 2023 /PRNewswire-PRWeb/ -- Shriners Children's, one of the largest pediatric sub-specialty healthcare systems in the world, has announced a multi-year national partnership with ThreePeaks Brands, Inc., a food and beverage company based near Phoenix.

Key Points: 
  • ThreePeaks Brands, Inc. will donate a portion of proceeds from all sales to Shriners Children's and its mission to improve the lives of children around the world.
  • "What Shriners Children's is doing to improve kids' lives from a medical perspective, ThreePeaks Brands is doing from a nutritional perspective."
  • As part of the agreement, ThreePeaks Brands, Inc. will donate a portion of proceeds from all sales to Shriners Children's and its mission to improve the lives of children around the world.
  • What Shriners Children's is doing to improve kids' lives from a medical perspective, ThreePeaks Brands is doing from a nutritional perspective.

The Inner Circle Acknowledges, Carrie Watson, DO, FACOS, FACS as a Top Pinnacle Healthcare Professional for her contributions to the Trauma Surgery Field

Retrieved on: 
Wednesday, October 11, 2023

ROCK HILL, S.C., Oct. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Carrie Watson, DO, FACOS, FACS is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the Trauma Surgery Field.

Key Points: 
  • ROCK HILL, S.C., Oct. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Carrie Watson, DO, FACOS, FACS is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the Trauma Surgery Field.
  • An exceptional resident, she was nationally recognized through the American College of Osteopathic Surgeons with the 2016 Resident Achievement Award.
  • A testament to her trauma surgery skills, she is also an instructor for Advanced Trauma Life Support.
  • She notes that trauma surgeons generally complete residency training in general surgery and often fellowship training in trauma or surgical critical care.